On April 23, 2009, I had the honor to participate in the third round of the “French Medical Days” tour organized by the French Consulate in Shanghai and the Shanghai Municipal Health Bureau. During this event, four internationally renowned French professors focused on topics of interest in the fields of emergency medicine, oncology, hepatitis and cardiovascular diseases from a public health perspective, providing valuable information and ideas to Chinese medical professionals. The theme of this session in the field of oncology was “Fighting and Curing Cancer” and the speaker was Prof. Pro Simon Schraub, President of the French International Cancer Collaboration. Tumors have become the number one cause of death in France, and their incidence and mortality have been increasing for 20 years. According to the World Health Organization, by 2020, there will be 20 million new cases of tumors each year, 70% of which live in countries that account for only 5% of global GDP. In response to the increasing incidence of cancer, France implemented the “Presidential Plan to Combat Cancer” from 2003 to 2007 (during the Chirac presidency) and established the National Institute to Combat Cancer in 2005, with the aim of coordinating action against cancer across a wide range of medical and non-medical sectors, setting clear objectives and defining priorities for action based on existing conditions. The second phase of the anti-cancer program will be implemented in France from 2009 to 2013. In the area of cancer prevention, the French government has increased the retail price of cigarettes and issued a “ban on smoking in public places” on November 15, 2006, to protect non-smokers from passive smoking. These measures led to a 30% decrease in tobacco sales in France between 2002 and 2008. Vaccination against hepatitis and papillomavirus to prevent liver and cervical cancers. For tumors with high incidence, such as breast, colorectal and cervical cancers, free screening actions are organized with the aim of early diagnosis, improved prognosis and reduced overall cost of treatment. In response to the fragmentation of treatment management and the uneven quality of treatment, the Cancer Plan calls for the organization of treatment networks (establishment of regional oncology centers) and the provision of reference points for treatment, as well as the accreditation of hospitals with high quality of care. The importance of good training of specialists and multidisciplinary cooperation is emphasized, requiring the organization of multidisciplinary dialogue meetings (mandatory in France since 2007, with formal reporting of decisions) and the implementation of standardized oncology treatment for patients (good cooperation between disciplines can increase cure rates by 10%). In response to the increased cost of using new drugs and treatments, the French government has, on the one hand, increased the government’s financial commitment and, on the other hand, emphasized the need to conduct an assessment of the absolute cost-benefit ratio, the correct implementation of existing measures (cheap and effective chemotherapy products), and the rational selection of drugs. Emphasis was placed on the importance of inexpensive adjuvant therapy to improve the quality of survival of patients. Finally, Prof. Shi Haobo suggested that China adopt the WHO recommendations to implement the anti-cancer program and is willing to work with Chinese experts to develop treatment standards for the most common tumors in China (cervical cancer, breast cancer, rectal cancer ……) and then promote and comply with the above standards.